Monday Aug 18
LipoScience Sets New 12-Month Low at $2.84
LipoScience shares reached a new 52-week low on Monday , StockRatingsNetwork.com reports.
LipoScience, Inc. (LPDX) - Financial and Strategic SWOT Analysis Review - New Market Study Published
Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations.
LipoScience (LPDX) Releases Quarterly Earnings, Misses Expectations By $0.03 EPS
LipoScience announced its earnings results on Wednesday. The company reported earnings per share for the quarter, missing the analysts' consensus estimate of by $0.03, AmericanBankingNews.com reports.
LipoScience's (LPDX) CEO Howard Doran on Q2 2014 Results - Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the LipoScience Second Quarter 2014 Earnings Results Conference Call.
LipoScience still feeling pain from terminating contract
Raleigh diagnostics company LipoScience Inc. continued to feel the aftershocks of terminating a profitable contract as quarterly revenue decreased 25 percent sequentially and 32 percent compared with last year.
LipoScience to Release Second Quarter 2014 Financial Results
LipoScience, Inc. today announced that it will release its second quarter 2014 financial results after the market close on Tuesday, August 12, 2014.
GliaCure Appoints New Member To Board Of Directors
He has held various executive positions in the biotechnology and pharmaceutical industry and has served on the Board of Directors of publicly held companies Acceleron Pharmaceuticals, Amarin Pharmaceuticals, Insulet Corporation, and Liposcience.